Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-5661
Fax+1 216-844-1900
Dr. Larchian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Larchian is a urologist based in Cleveland, OH, specializing in minimally invasive surgery and surgical oncology. He completed his medical education at Boston University School of Medicine and furthered his training with residencies in urology and surgery, followed by a fellowship in urologic surgery at Duke University Hospital and urologic oncology at Memorial Sloan-Kettering Cancer Center in New York City. Currently an Associate Professor of Surgery at University Hospitals Cleveland Medical Center, he has expertise in prostate, bladder, and testicular cancers, as well as in animal disease models and cultured tumor cells. Dr. Larchian has contributed to the field through multiple publications on topics such as tumor boards and bladder cancer models, with several of his works being cited numerous times by other researchers.
Education & Training
Duke University HospitalFellowship, Minimally Invasive Urologic Surgery, 1993 - 1995
Boston University Medical CenterResidency, Urology, 1989 - 1993
UMass Chan Medical SchoolResidency, Surgery, 1984 - 1986
Boston University School of MedicineClass of 1984
Certifications & Licensure
OH State Medical License 1997 - 2026
NY State Medical License 1989 - 1998
Publications & Presentations
PubMed
- 18 citationsEvaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?Kyle Scarberry, Lee Ponsky, Edward E. Cherullo, William A. Larchian, Donald R. Bodner
Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada. 2018-05-14 - 10 citationsSunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic modelEddie Shu-Yin Chan, Amit R. Patel, Donna E. Hansel, William A. Larchian, Warren D. Heston
Urology. 2012-09-01 - 8 citationsIn Vivo Targeted Contrast Enhanced Micro-Ultrasound to Measure Intratumor Perfusion and Vascular Endothelial Growth Factor Receptor 2 Expression in a Mouse Orthotopic ...Eddie Shu-Yin Chan, Amit R. Patel, William A. Larchian, Warren D. Heston
The Journal of Urology. 2011-06-01
Press Mentions
UH Elyria Medical Center Celebrates 110th AnniversaryOctober 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
